274 related articles for article (PubMed ID: 15612859)
1. Cue-provoked craving and nicotine replacement therapy in smoking cessation.
Waters AJ; Shiffman S; Sayette MA; Paty JA; Gwaltney CJ; Balabanis MH
J Consult Clin Psychol; 2004 Dec; 72(6):1136-43. PubMed ID: 15612859
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving.
Shiffman S; Shadel WG; Niaura R; Khayrallah MA; Jorenby DE; Ryan CF; Ferguson CL
Psychopharmacology (Berl); 2003 Apr; 166(4):343-50. PubMed ID: 12601502
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of rapid-release nicotine gum versus nicotine polacrilex gum in relieving smoking cue-provoked craving.
Niaura R; Sayette M; Shiffman S; Glover ED; Nides M; Shelanski M; Shadel W; Koslo R; Robbins B; Sorrentino J
Addiction; 2005 Nov; 100(11):1720-30. PubMed ID: 16277632
[TBL] [Abstract][Full Text] [Related]
4. Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers.
Tiffany ST; Cox LS; Elash CA
J Consult Clin Psychol; 2000 Apr; 68(2):233-40. PubMed ID: 10780123
[TBL] [Abstract][Full Text] [Related]
5. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
[TBL] [Abstract][Full Text] [Related]
6. Effects of varenicline versus transdermal nicotine replacement therapy on cigarette demand on quit day in individuals with substance use disorders.
Murphy CM; MacKillop J; Martin RA; Tidey JW; Colby SM; Rohsenow DJ
Psychopharmacology (Berl); 2017 Aug; 234(16):2443-2452. PubMed ID: 28500373
[TBL] [Abstract][Full Text] [Related]
7. Effect of nicotine lozenge use prior to smoking cue presentation on craving and withdrawal symptom severity.
Kotlyar M; Vogel RI; Dufresne SR; Mills AM; Vuchetich JP
Drug Alcohol Depend; 2020 Jan; 206():107706. PubMed ID: 31757519
[TBL] [Abstract][Full Text] [Related]
8. A placebo-controlled randomized trial of D-cycloserine augmentation of cue exposure therapy for smoking cessation.
Otto MW; Pachas GN; Cather C; Hoeppner SS; Moshier SJ; Hearon BA; Ward HB; Laffer AB; Smits JAJ; Evins AE
Cogn Behav Ther; 2019 Jan; 48(1):65-76. PubMed ID: 30111253
[TBL] [Abstract][Full Text] [Related]
9. The relevance and treatment of cue-induced cravings in tobacco dependence.
Ferguson SG; Shiffman S
J Subst Abuse Treat; 2009 Apr; 36(3):235-43. PubMed ID: 18715743
[TBL] [Abstract][Full Text] [Related]
10. Reactivity to nicotine cues over repeated cue reactivity sessions.
LaRowe SD; Saladin ME; Carpenter MJ; Upadhyaya HP
Addict Behav; 2007 Dec; 32(12):2888-99. PubMed ID: 17537583
[TBL] [Abstract][Full Text] [Related]
11. Effects of transdermal nicotine during imaginal exposure to anxiety and smoking cues in college smokers.
Morissette SB; Palfai TP; Gulliver SB; Spiegel DA; Barlow DH
Psychol Addict Behav; 2005 Jun; 19(2):192-8. PubMed ID: 16011390
[TBL] [Abstract][Full Text] [Related]
12. Comparison of nicotine oral soluble film and nicotine lozenge on efficacy in relief of smoking cue-provoked acute craving after a single dose of treatment in low dependence smokers.
Du D; Nides M; Borders J; Selmani A; Waverczak W
Psychopharmacology (Berl); 2014 Nov; 231(22):4383-91. PubMed ID: 24781517
[TBL] [Abstract][Full Text] [Related]
13. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
14. Does acute tobacco smoking prevent cue-induced craving?
Schlagintweit HE; Barrett SP
J Psychopharmacol; 2016 May; 30(5):468-73. PubMed ID: 27026532
[TBL] [Abstract][Full Text] [Related]
15. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
[TBL] [Abstract][Full Text] [Related]
16. Nicotine replacement therapy for smoking cessation.
Stead LF; Perera R; Bullen C; Mant D; Lancaster T
Cochrane Database Syst Rev; 2008 Jan; (1):CD000146. PubMed ID: 18253970
[TBL] [Abstract][Full Text] [Related]
17. Nicotine replacement therapy for smoking cessation.
Silagy C; Mant D; Fowler G; Lancaster T
Cochrane Database Syst Rev; 2000; (2):CD000146. PubMed ID: 10796494
[TBL] [Abstract][Full Text] [Related]
18. The impact of anticipated and unanticipated smoking opportunities on cigarette smoking and nicotine lozenge responses.
Schlagintweit HE; Greer H; Good KP; Barrett SP
Drug Alcohol Depend; 2015 Feb; 147():97-102. PubMed ID: 25561388
[TBL] [Abstract][Full Text] [Related]
19. Decline in cue-provoked craving during cue exposure therapy for smoking cessation.
Unrod M; Drobes DJ; Stasiewicz PR; Ditre JW; Heckman B; Miller RR; Sutton SK; Brandon TH
Nicotine Tob Res; 2014 Mar; 16(3):306-15. PubMed ID: 24078760
[TBL] [Abstract][Full Text] [Related]
20. Dissociable effect of acute varenicline on tonic versus cue-provoked craving in non-treatment-motivated heavy smokers.
Hitsman B; Hogarth L; Tseng LJ; Teige JC; Shadel WG; DiBenedetti DB; Danto S; Lee TC; Price LH; Niaura R
Drug Alcohol Depend; 2013 Jun; 130(1-3):135-41. PubMed ID: 23201174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
